Chen; Yao-tseng

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chen; Yao-tseng.The latest application filed is for "method for inducing cell lysis with immunogenic portions of ny-eso-1 protein".

Company Profile

0.29.22

Chen; Yao-tseng - New York NY
Chen; Yao-Tseng - NY NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein Grant 8,541,202 - Knuth , et al. September 24, 2	2013-09-24
Method For Inducing Cell Lysis With Immunogenic Portions Of Ny-eso-1 Protein App 20120231035 - Knuth; Alexander ; et al.	2012-09-13
Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein Grant 8,142,786 - Knuth , et al. March 27, 2	2012-03-27
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 8,071,717 - Jager , et al. December 6, 2	2011-12-06
Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein App 20110182944 - Knuth; Alexander ; et al.	2011-07-28
Cancer-testis antigens App 20110177079 - Chen; Yao-Tseng ; et al.	2011-07-21
Isolated nucleic acid molecules which encode immunogenic portions of NY-ESO-1 protein Grant 7,888,100 - Knuth , et al. February 15, 2	2011-02-15
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof App 20100278850 - Jager; Dirk ; et al.	2010-11-04
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof Grant 7,795,409 - Jager , et al. September 14, 2	2010-09-14
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 7,622,568 - Jager , et al. November 24, 2	2009-11-24
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof App 20090203123 - Jager; Dirk ; et al.	2009-08-13
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof App 20080177031 - Jager; Dirk ; et al.	2008-07-24
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 7,354,992 - Jager , et al. April 8, 2	2008-04-08
Breast cancer antigens Grant 7,335,467 - Scanlan , et al. February 26, 2	2008-02-26
Small cell lung cancer associated antigens and uses therefor Grant 7,314,721 - Gure , et al. January 1, 2	2008-01-01
Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof Grant 7,291,335 - Stockert , et al. November 6, 2	2007-11-06
Isolated peptides corresponding to amino acid requirements of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof App 20060269960 - Knuth; Alexander ; et al.	2006-11-30
Isolated cancer associated antigens NY-MEL 1 and NY-MEL 3, peptides based thereon, and their uses Grant 7,132,507 - Jager , et al. November 7, 2	2006-11-07
Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53 Grant 7,115,729 - Knuth , et al. October 3, 2	2006-10-03
Cancer-testis antigens App 20060089303 - Old; Lloyd J. ; et al.	2006-04-27
Isolated peptides which bind to HLA-C molecules and uses thereof Grant 7,009,035 - Gnjatic , et al. March 7, 2	2006-03-07
Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer Grant 6,982,316 - Scanlan , et al. January 3, 2	2006-01-03
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 6,911,529 - Jager , et al. June 28, 2	2005-06-28
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof App 20050063981 - Jager, Dirk ; et al.	2005-03-24
Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof Grant 6,830,924 - Chen , et al. December 14, 2	2004-12-14
Cancer-testis antigens App 20040235066 - Old, Lloyd J. ; et al.	2004-11-25
Colon cancer antigen panel Grant 6,794,501 - Chen , et al. September 21, 2	2004-09-21
Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53 App 20040158044 - Knuth, Alexander ; et al.	2004-08-12
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 6,774,226 - Jager , et al. August 10, 2	2004-08-10
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof App 20040126398 - Jager, Dirk ; et al.	2004-07-01
Small cell lung cancer associated antigens and uses therefor App 20040126808 - Gure, Ali O. ; et al.	2004-07-01
Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof Grant 6,723,832 - Knuth , et al. April 20, 2	2004-04-20
Cancer associated antigens and uses therefor Grant 6,686,147 - Scanlan , et al. February 3, 2	2004-02-03
Colon cancer antigen panel App 20030165834 - Chen, Yao-Tseng ; et al.	2003-09-04
Breast cancer antigens App 20030108888 - Scanlan, Matthew J. ; et al.	2003-06-12
Isolated peptides which bind to HLA-C molecules and uses thereof App 20030050451 - Gnjatic, Sacha ; et al.	2003-03-13
Cancer-testis antigens App 20030044813 - Old, Lloyd J. ; et al.	2003-03-06
Truncated forms of NY-ESO-1 protein Grant 6,525,177 - Stockert , et al. February 25, 2	2003-02-25
Antibodies specific for SSX proteins App 20030023057 - Gure, Ali O. ; et al.	2003-01-30
Isolated cancer associated antigens NY-MEL 1 and NY-MEL 3, peptides based thereon, and their uses App 20030017547 - Jager, Dirk ; et al.	2003-01-23
Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof App 20020164665 - Stockert, Elisabeth ; et al.	2002-11-07
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 6,448,073 - Jager , et al. September 10, 2	2002-09-10
Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof App 20020111470 - Chen, Yao-Tseng ; et al.	2002-08-15
Isolated nucleic acid molecules associated with colon, renal, and stomach cancer and methods of using these Grant 6,403,373 - Scanlan , et al. June 11, 2	2002-06-11
Compositions containing a p53 derived protein or peptide, an adjuvant, and interleukin-12 and uses thereof Grant 6,355,256 - Noguchi , et al. March 12, 2	2002-03-12
Truncated forms of NY-ESO-1 protein App 20020010321 - Chen, Yao-tseng ; et al.	2002-01-24
Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith Grant 6,338,947 - Sahin , et al. January 15, 2	2002-01-15
Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof Grant 6,274,145 - Chen , et al. August 14, 2	2001-08-14
Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof Grant 6,069,233 - Chen , et al. May 30, 2	2000-05-30
Monoclonal antibodies which bind to tumor rejection antigen precursor melan-A, and uses thereof Grant 5,674,749 - Chen , et al. October 7, 1	1997-10-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.